KPV: Dosage, Benefits & Research Guide
What is KPV?
KPV (Lysine-Proline-Valine) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), specifically positions 11-13. Despite being only three amino acids, KPV retains the potent anti-inflammatory activity of the full-length hormone while lacking melanotropic and steroidogenic effects. KPV suppresses inflammation by inhibiting NF-kB nuclear translocation and reducing pro-inflammatory cytokine production, including IL-1beta, IL-6, and TNF-alpha. It enters cells and interacts directly with inflammatory signaling cascades independently of melanocortin receptors. Research published in the Journal of Biological Chemistry by Brzoska et al. demonstrated that KPV inhibited NF-kB activation in human intestinal epithelial cells, reducing inflammatory gene expression by 60-80% at micromolar concentrations. Studies in murine colitis models published in Inflammatory Bowel Diseases showed that oral and intracolonic KPV administration significantly reduced disease activity index scores, colonic inflammation, and histological damage. Dalmasso et al. (2008) in PLoS ONE confirmed that KPV-loaded nanoparticles effectively targeted inflamed colonic tissue and accelerated mucosal healing. Compared to full-length alpha-MSH, KPV offers the advantage of anti-inflammatory activity without pigmentation effects or hormonal side effects. Unlike conventional anti-inflammatory agents such as corticosteroids or NSAIDs, KPV targets intracellular NF-kB signaling rather than cyclooxygenase or glucocorticoid receptor pathways, representing a mechanistically distinct approach to inflammation modulation. Store lyophilized KPV at -20°C. Reconstitute with bacteriostatic water and refrigerate at 2-8°C, using within 4 weeks. KPV is researched by gastroenterologists studying inflammatory bowel disease, dermatologists investigating anti-inflammatory skin treatments, and immunologists examining NF-kB-dependent inflammatory pathways.
KPV Research Applications
In published and preclinical research, KPV has been studied across the following areas:
- Intestinal inflammation and IBD models
- Anti-inflammatory pathway modulation
- Wound healing and scar prevention
- Antimicrobial activity studies
KPV in Research: Reconstitution & Study Concentrations
KPV is supplied as a lyophilized powder. For laboratory research it is reconstituted with bacteriostatic or sterile water; the solvent volume sets the working concentration. Published studies select concentrations specific to the assay or model system — there is no human dose, as KPV is not approved for human use. Researchers should reference the primary literature for the model in question and document the exact lot COA.
Worked example: a 10mg vial reconstituted with 2 mL of bacteriostatic water yields 5.00 mg/mL.
Open the reconstitution calculator